Cargando…

Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages

SIMPLE SUMMARY: Wilms’ tumor (WT) is the most common childhood renal tumor accounting for approximately 7% of childhood malignancies. The overall survival rate for patients with favorable histology is greater than 90% while the survival rate for patients with poor prognostic factors is around 50%. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiore, Piera Filomena, Vacca, Paola, Tumino, Nicola, Besi, Francesca, Pelosi, Andrea, Munari, Enrico, Marconi, Marcella, Caruana, Ignazio, Pistoia, Vito, Moretta, Lorenzo, Azzarone, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826641/
https://www.ncbi.nlm.nih.gov/pubmed/33435455
http://dx.doi.org/10.3390/cancers13020224
_version_ 1783640568958550016
author Fiore, Piera Filomena
Vacca, Paola
Tumino, Nicola
Besi, Francesca
Pelosi, Andrea
Munari, Enrico
Marconi, Marcella
Caruana, Ignazio
Pistoia, Vito
Moretta, Lorenzo
Azzarone, Bruno
author_facet Fiore, Piera Filomena
Vacca, Paola
Tumino, Nicola
Besi, Francesca
Pelosi, Andrea
Munari, Enrico
Marconi, Marcella
Caruana, Ignazio
Pistoia, Vito
Moretta, Lorenzo
Azzarone, Bruno
author_sort Fiore, Piera Filomena
collection PubMed
description SIMPLE SUMMARY: Wilms’ tumor (WT) is the most common childhood renal tumor accounting for approximately 7% of childhood malignancies. The overall survival rate for patients with favorable histology is greater than 90% while the survival rate for patients with poor prognostic factors is around 50%. The current treatments consist in a combination of surgery and chemotherapy or radiotherapy in high risk patients. Such treatments are responsible for significant adverse effects requiring long-term monitoring. Thus, a main challenge in WT treatment is the development of novel therapeutic strategies to eliminate or minimize the adverse effects. The characterization of an immune environment could allow the identification of new therapeutic targets. Herein we studied the interaction between WT and innate immune cells, in particular NK cells and monocytes. Although WT are highly susceptible to NK-mediated lysis, the detection of immunoregulatory activity of WT tumor cells on NK cells and also on monocytes could offer novel cellular and molecular targets for an efficacious immunotherapy of WT. ABSTRACT: The immune response plays a crucial defensive role in cancer growth and metastasis and is a promising target in different tumors. The role of the immune system in Wilm’s Tumor (WT), a common pediatric renal malignancy, is still to be explored. The characterization of the immune environment in WT could allow the identification of new therapeutic strategies for targeting possible inhibitory mechanisms and/or lowering toxicity of the current treatments. In this study, we stabilized four WT primary cultures expressing either a blastematous (CD56(+)/CD133(−)) or an epithelial (CD56(−)/CD133(+)) phenotype and investigated their interactions with innate immune cells, namely NK cells and monocytes. We show that cytokine-activated NK cells efficiently kill WT cells. However, after co-culture with WT primary cells, NK cells displayed an impaired cytotoxic activity, decreased production of IFNγ and expression of CD107a, DNAM-1 and NKp30. Analysis of the effects of the interaction between WT cells and monocytes revealed their polarization towards alternatively activated macrophages (M2) that, in turn, further impaired NK cell functions. In conclusion, we show that both WT blastematous and epithelial components may contribute directly and indirectly to a tumor immunosuppressive microenvironment that is likely to play a role in tumor progression.
format Online
Article
Text
id pubmed-7826641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78266412021-01-25 Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages Fiore, Piera Filomena Vacca, Paola Tumino, Nicola Besi, Francesca Pelosi, Andrea Munari, Enrico Marconi, Marcella Caruana, Ignazio Pistoia, Vito Moretta, Lorenzo Azzarone, Bruno Cancers (Basel) Article SIMPLE SUMMARY: Wilms’ tumor (WT) is the most common childhood renal tumor accounting for approximately 7% of childhood malignancies. The overall survival rate for patients with favorable histology is greater than 90% while the survival rate for patients with poor prognostic factors is around 50%. The current treatments consist in a combination of surgery and chemotherapy or radiotherapy in high risk patients. Such treatments are responsible for significant adverse effects requiring long-term monitoring. Thus, a main challenge in WT treatment is the development of novel therapeutic strategies to eliminate or minimize the adverse effects. The characterization of an immune environment could allow the identification of new therapeutic targets. Herein we studied the interaction between WT and innate immune cells, in particular NK cells and monocytes. Although WT are highly susceptible to NK-mediated lysis, the detection of immunoregulatory activity of WT tumor cells on NK cells and also on monocytes could offer novel cellular and molecular targets for an efficacious immunotherapy of WT. ABSTRACT: The immune response plays a crucial defensive role in cancer growth and metastasis and is a promising target in different tumors. The role of the immune system in Wilm’s Tumor (WT), a common pediatric renal malignancy, is still to be explored. The characterization of the immune environment in WT could allow the identification of new therapeutic strategies for targeting possible inhibitory mechanisms and/or lowering toxicity of the current treatments. In this study, we stabilized four WT primary cultures expressing either a blastematous (CD56(+)/CD133(−)) or an epithelial (CD56(−)/CD133(+)) phenotype and investigated their interactions with innate immune cells, namely NK cells and monocytes. We show that cytokine-activated NK cells efficiently kill WT cells. However, after co-culture with WT primary cells, NK cells displayed an impaired cytotoxic activity, decreased production of IFNγ and expression of CD107a, DNAM-1 and NKp30. Analysis of the effects of the interaction between WT cells and monocytes revealed their polarization towards alternatively activated macrophages (M2) that, in turn, further impaired NK cell functions. In conclusion, we show that both WT blastematous and epithelial components may contribute directly and indirectly to a tumor immunosuppressive microenvironment that is likely to play a role in tumor progression. MDPI 2021-01-09 /pmc/articles/PMC7826641/ /pubmed/33435455 http://dx.doi.org/10.3390/cancers13020224 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fiore, Piera Filomena
Vacca, Paola
Tumino, Nicola
Besi, Francesca
Pelosi, Andrea
Munari, Enrico
Marconi, Marcella
Caruana, Ignazio
Pistoia, Vito
Moretta, Lorenzo
Azzarone, Bruno
Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title_full Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title_fullStr Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title_full_unstemmed Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title_short Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages
title_sort wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826641/
https://www.ncbi.nlm.nih.gov/pubmed/33435455
http://dx.doi.org/10.3390/cancers13020224
work_keys_str_mv AT fiorepierafilomena wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT vaccapaola wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT tuminonicola wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT besifrancesca wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT pelosiandrea wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT munarienrico wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT marconimarcella wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT caruanaignazio wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT pistoiavito wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT morettalorenzo wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages
AT azzaronebruno wilmstumorprimarycellsdisplaypotentimmunoregulatorypropertiesonnkcellsandmacrophages